Compound class:
Synthetic organic
Comment: Compound 29 is reported as a colony-stimulating factor 1 receptor (CSF-1R) inhibitor [1]. It was identified by high-throughput screening, and virtual docking and structure-activity-relationship (SAR) studies. The chemical structure of compound 29 represents a novel class of o-aminopyridyl alkynyl-based inhibitor for this kinase. Compound 29 elicits anti-inflammatory effects in vitro..
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 29 does not inhibit FMS-like tyrosine kinase 3 (FLT3) which belongs to the same receptor tyrosine kinase family as the CSF-1R [1]. In a kinase selectivity screening panel, only PDGFRα and cKIT were inhibited by >50% by 10 nM compound 29. At 100 nM several other tyrosine kinases were inhibited by >70%; VEGFR1, VEGFR2, PDGFRα, PDGFRβ, RET, cKIT and Abl. |
Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|